“…Furthermore, in the Trans-Omics for Precision Medicine (TOPMed) Program, only $10% of its 145,000 samples are Asians (Taliun et al, 2019). In Asia, most published WGS studies have small sample sizes (Bai et al, 2018;Wong et al, 2013Wong et al, , 2014, except for two recent studies of Chinese by 1.73 and 0.13 WGS, respectively (Chiang et al, 2018;Liu et al, 2018). Extremely shallow sequencing, however, has low sensitivity to detect rare variants and, thus, limited power for evolutionary inferences and other population genetics analyses (Li et al, 2011;Han et al, 2014).…”